Schmidt, Angelika http://orcid.org/0000-0002-1185-3012
Marabita, Francesco
Kiani, Narsis A.
Gross, Catharina C.
Johansson, Henrik J.
Éliás, Szabolcs
Rautio, Sini
Eriksson, Matilda
Fernandes, Sunjay Jude
Silberberg, Gilad
Ullah, Ubaid
Bhatia, Urvashi
Lähdesmäki, Harri
Lehtiö, Janne
Gomez-Cabrero, David
Wiendl, Heinz
Lahesmaa, Riitta
Tegnér, Jesper
Funding for this research was provided by:
Academy of Finland (256355, 256355, 256355, 250114, 250114, 294337)
FP7 People: Marie-Curie Actions (326930)
Dr. Åke Olsson Foundation
CERIC
CERIC
European Research Council (617393, 617393, 617393)
Vetenskapsrådet (2011-3264)
Torsten Söderbergs Stiftelse
FP7-Health (306000)
VINNOVA
Deutsche Forschungsgemeinschaft (CRC 128, CRC 128, Immunology Initiative, Immunology Initiative, Immunology Initiative)
Bundesministerium für Bildung und Forschung (FKZ 01FI1603a, FKZ 01FI1603a)
Sigrid Juséliuksen Säätiö
Paulo Foundation
Karolinska Institutet (Stiftelser & Fonder, Stiftelser & Fonder, Stiftelser & Fonder, Stiftelser & Fonder, KID funding)
Erik och Edith Fernström Foundation
DGfI and Euroimmun AG
AFA Försäkring
Stockholms Läns Landsting
Stratneuro
Cluster of Excellence “Cells in Motion” Bridging Fund
Article History
Received: 3 April 2018
Accepted: 10 April 2018
First Online: 7 May 2018
Ethics approval and consent to participate
: The experimental methods comply with the Declaration of Helsinki and ethical approval was obtained as appropriate and is detailed in the respective Methods sections.
: CCG received speaker honoraria and travel expenses for attending meetings from Bayer Health Care, Genzyme, and Novartis Pharma GmbH and her research is funded by the Interdisciplinary Center for Clinical Studies (IZKF). HW receives honoraria for acting as a member of Scientific Advisory Boards and as consultant for Biogen, Evgen, MedDay Pharmaceuticals, Merck Serono, Novartis, Roche Pharma AG, Sanofi-Genzyme, as well as speaker honoraria and travel support from Alexion, Biogen, Cognomed, F. Hoffmann-La Roche Ltd., Gemeinnützige Hertie-Stiftung, Merck Serono, Novartis, Roche Pharma AG, Sanofi-Genzyme, TEVA, and WebMD Global. HW is acting as a paid consultant for Abbvie, Actelion, Biogen, IGES, Novartis, Roche, Sanofi-Genzyme, and the Swiss Multiple Sclerosis Society. HW received research funding from the Else Kröner Fresenius Foundation, Fresenius Foundation, Hertie Foundation, NRW Ministry of Education and Research, IZKF Muenster and RE Children’s Foundation, Biogen GmbH, GlaxoSmithKline GmbH, Roche Pharma AG, and Sanofi-Genzyme.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.All other authors declare no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.